Immune Globulins Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (IgG, IgA, IgM, IgE, IgD); Route of Administration (Intravenous, Subcutaneous); Application (Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Others); and Geography
Report Code: TIPRE00021154 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
Immune globulin (Ig) is a sterile solution made with human plasma which significantly provides short-term, immediate protection against measles infections and hepatitis A. Also, it reduces the risk of infection in the immunocompromised patient, who have a decreased ability to produce antibodies. Moreover, these Immune globulin (Ig) solutions are available in both powder as well as liquid form.
MARKET DYNAMICS
Increasing prevalence of blood-related diseases and exponential growth in geriatric population are actively contributing to the growth of immune globulins market. However, high cost and increased risk of side effects are expected to hamper the market growth.
MARKET SCOPE
The "Immune Globulins Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Immune Globulins Market with detailed market segmentation by type, route of administration, and application. The Immune Globulins Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Immune Globulins Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Immune Globulins Market is segmented on the basis of type, route of administration, and application. On the basis of type, the market is segmented as IgG, IgA, IgM, IgE, and IgD. Based on route of administration, the market is segmented as intravenous and subcutaneous. On the basis of application, the market is segmented as multifocal motor neuropathy, idiopathic thrombocytopenic purpura, inflammatory myopathies, specific antibody deficiency, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Immune Globulins Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Immune Globulins Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Immune Globulins Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Immune Globulins Market in these regions.
The report covers key developments in the Immune Globulins Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Immune Globulins Market are anticipated to have lucrative growth opportunities in the future with the rising demand for smart hospital beds in the global market. Below mentioned is the list of few companies engaged in the Immune Globulins Market.
The report also includes the profiles of key players in Immune Globulins Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Immune globulin (Ig) is a sterile solution made with human plasma which significantly provides short-term, immediate protection against measles infections and hepatitis A. Also, it reduces the risk of infection in the immunocompromised patient, who have a decreased ability to produce antibodies. Moreover, these Immune globulin (Ig) solutions are available in both powder as well as liquid form.
MARKET DYNAMICS
Increasing prevalence of blood-related diseases and exponential growth in geriatric population are actively contributing to the growth of immune globulins market. However, high cost and increased risk of side effects are expected to hamper the market growth.
MARKET SCOPE
The "Immune Globulins Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Immune Globulins Market with detailed market segmentation by type, route of administration, and application. The Immune Globulins Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Immune Globulins Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Immune Globulins Market is segmented on the basis of type, route of administration, and application. On the basis of type, the market is segmented as IgG, IgA, IgM, IgE, and IgD. Based on route of administration, the market is segmented as intravenous and subcutaneous. On the basis of application, the market is segmented as multifocal motor neuropathy, idiopathic thrombocytopenic purpura, inflammatory myopathies, specific antibody deficiency, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Immune Globulins Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Immune Globulins Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Immune Globulins Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Immune Globulins Market in these regions.
The report covers key developments in the Immune Globulins Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Immune Globulins Market are anticipated to have lucrative growth opportunities in the future with the rising demand for smart hospital beds in the global market. Below mentioned is the list of few companies engaged in the Immune Globulins Market.
The report also includes the profiles of key players in Immune Globulins Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Baxter international Inc.
- CSL Ltd.
- Octapharma AG
- Kedrion Biopharma Inc.
- LFB group
- Biotest AG
- China Biologics Products, Inc.
- Bayer Healthcare
- ADMA Biologics, Inc.
- BioScrip, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
The List of Companies
1. Baxter international Inc.
2. CSL Ltd. Grifols S.A
3. Octapharma AG
4. Kedrion Biopharma Inc.
5. LFB group
6. Biotest AG
7. China Biologics Products, Inc.
8. Bayer Healthcare
9. ADMA Biologics, Inc.
10. BioScrip, Inc.
1. Baxter international Inc.
2. CSL Ltd. Grifols S.A
3. Octapharma AG
4. Kedrion Biopharma Inc.
5. LFB group
6. Biotest AG
7. China Biologics Products, Inc.
8. Bayer Healthcare
9. ADMA Biologics, Inc.
10. BioScrip, Inc.
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount